Skip to search formSkip to main contentSkip to account menu

PRALMORELIN

Known as: Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2, D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, growth hormone-releasing peptide-2 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Growth SubstancesOligopeptides

Narrower (1)

KP 102
pralmorelin dihydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Metabolism of growth hormone releasing peptides.
New, potentially performance enhancing compounds have frequently been introduced to licit and illicit markets and rapidly… 
Highly Cited
2011
Highly Cited
2011
Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry
A family of small peptides has reached the focus of doping controls representing a comparably new strategy for cheating sportsmen… 
Highly Cited
2010
Highly Cited
2010
Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.
GHRP-2 (pralmorelin, D-Ala-D-(beta-naphthyl)-Ala-Ala-Trp-D-Phe-Lys-NH(2)), which belongs to a class of growth hormone… 
Highly Cited
2007
Highly Cited
2007
A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.
OBJECTIVE The international, first-line diagnostic test for adult GH deficiency is the insulin tolerance test (ITT), which is… 
Highly Cited
2005
Highly Cited
2005
Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Chronic arthritis is a catabolic state associated with an inhibition of the IGF system and a decrease in body weight. Cachexia… 
Highly Cited
2002
Highly Cited
2002
GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein.
Ghrelin, an endogenous GH secretagogue, is capable of stimulating adiposity in rodents. Because such adiposity was thought to be… 
Highly Cited
1999
Highly Cited
1999
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.
Protracted critical illness is marked by protein wasting resistant to feeding, by accumulation of fat stores, and by suppressed… 
Highly Cited
1998
Highly Cited
1998
Ipamorelin, the first selective growth hormone secretagogue.
The development and pharmacology of a new potent growth hormone (GH) secretagogue, ipamorelin, is described. Ipamorelin is a… 
1996
1996
Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.
This study was conducted to determine the effects of acute and chronic administration of GH-releasing peptide-2 (D-Ala-D-beta Nal… 
Highly Cited
1993
Highly Cited
1993
GH Releasing Peptides - Structure and Kinetics
A new class of small synthetic peptides has been developed which specifically release GH. They consist of 6-7 amino acids and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)